Funds and ETFs Rockwell Medical, Inc.

Equities

RMTI

US7743743004

Pharmaceuticals

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
1.455 USD -3.64% Intraday chart for Rockwell Medical, Inc. +0.34% -23.02%
Rockwell Medical, Inc. is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers around the world. It operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. It is the supplier of life-sustaining hemodialysis concentrates products to dialysis clinics. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. Its first two branded products from its ferric pyrophosphate citrate (FPC) platform, Triferic (dialysate) and Triferic AVNU, are indicated to maintain hemoglobin in patients undergoing hemodialysis. It offers dry and liquid citric acid, acetic acid, and bicarbonate hemodialysis products.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
1.455 USD
Average target price
7 USD
Spread / Average Target
+381.10%
Consensus
  1. Stock Market
  2. Equities
  3. RMTI Stock
  4. Funds and ETFs Rockwell Medical, Inc.